Toyoda Gosei Co., Ltd. (11T.F)
| Previous close | 18.50 |
| Open | 18.30 |
| Bid | 18.30 x 12700 |
| Ask | 18.80 x 12500 |
| Day's range | 18.30 - 18.30 |
| 52-week range | 14.80 - 21.80 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 2.363B |
| Beta (5Y monthly) | 0.71 |
| PE ratio (TTM) | 7.62 |
| EPS (TTM) | 2.40 |
| Earnings date | 26 July 2024 - 30 July 2024 |
| Forward dividend & yield | 0.66 (3.58%) |
| Ex-dividend date | 27 Sept 2024 |
| 1y target est | N/A |
Business WireToyoda Gosei Develops UV-C LED with World-Class Light Output
KIYOSU, Japan, April 22, 2024--Toyoda Gosei Co., Ltd. (TOKYO:7282) has developed deep ultraviolet (UV-C) LEDs with light output that is among the highest in the world.1 UV-C is used in disinfection as it destroys viral and bacterial DNA structures and inhibits their replication. As an alternative light source for mercury lamps used for disinfection, improved performance of UV-C LEDs has been expected. Sample sales of Toyoda Gosei’s high power LEDs will begin internationally from April 2024,2 to
Business WireToyoda Gosei’s High-Pressure Hydrogen Tank to be Used on Passenger Ship
KIYOSU, Japan, April 02, 2024--Toyoda Gosei’s high-pressure hydrogen tanks are being used on a passenger ship powered by hydrogen and other environmentally-friendly energy.
Business WireToyoda Gosei Invests in Yuurea, Inc., a Startup Developing Urine Test Kits for Easy Checks of Physical Condition
KIYOSU, Japan, March 25, 2024--Toyoda Gosei Co., Ltd. (TOKYO:7282), as one part of its efforts to develop new businesses that will help to resolve societal challenges in the healthcare field, has invested* in Yuurea, Inc., a company that develops test kits which will allow people to monitor their physical condition simply, using urine samples.
